| Ticker Details |
|
Precigen, Inc.
|
| IPO Date: |
August 9, 2013 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$1.51B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.13 | 4.21%
|
| Avg Daily Range (30 D): |
$0.12 | 3.37%
|
| Avg Daily Range (90 D): |
$0.15 | 3.58%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
1.75M |
| Avg Daily Volume (30 D): |
4.6M |
| Avg Daily Volume (90 D): |
4.01M |
| Trade Size |
| Avg Trade Size (Sh.): |
208 |
| Avg Trade Size (Sh.) (30 D): |
191 |
| Avg Trade Size (Sh.) (90 D): |
182 |
| Institutional Trades |
| Total Institutional Trades: |
575 |
| Avg Institutional Trade: |
$1.57M |
| Avg Institutional Trade (30 D): |
$1.66M |
| Avg Institutional Trade (90 D): |
$1.86M |
| Avg Institutional Trade Volume: |
.37M |
| Avg Institutional Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$1.67M |
| Avg Closing Trade (30 D): |
$1.9M |
| Avg Closing Trade (90 D): |
$2.1M |
| Avg Closing Volume: |
390.21K |
|
|
| Financials |
| |
TTM |
Q4 2025 |
FY 2025 |
|
Basic EPS
|
$-1.37
|
$-.01
|
$-1.37
|
|
Diluted EPS
|
$-1.37
|
$-.01
|
$-1.37
|
|
Revenue
|
$9.68M
|
|
$9.68M
|
|
Gross Profit
|
|
|
|
|
Net Income / Loss
|
$-250.64M
|
$-23.5M
|
$-250.64M
|
|
Operating Income / Loss
|
$-110.51M
|
|
$-110.51M
|
|
Cost of Revenue
|
|
|
|
|
Net Cash Flow
|
$.72M
|
$15.91M
|
$.72M
|
|
PE Ratio
|
|
|
|
|
|
|